According to a new report by Expert Market Research, the Biopsy Devices Market is valued at USD 7.82 Billion in 2025 and is projected to grow at a CAGR of 7.6% from 2026 to 2035, reaching USD 16.27 Billion by 2035. Moreover, rising cancer prevalence and diagnostic innovation continue to strengthen demand globally.
Furthermore, the is expanding rapidly due to increasing adoption of minimally invasive diagnostic procedures. Additionally, Expert Market Research highlights that technological improvements in image guidance systems are enhancing diagnostic accuracy across clinical settings.
Moreover, the market is driven by rising awareness of early cancer detection and improved healthcare infrastructure. Consequently, hospitals and diagnostic centers are increasingly adopting advanced biopsy tools. Furthermore, innovation in liquid biopsy techniques is supporting faster and less invasive diagnostics across multiple disease areas.
Request a Free Sample Report Featuring the Complete Table of Contents
Overall, the market outlook remains highly positive as healthcare systems prioritize precision diagnostics. Therefore, Expert Market Research emphasizes steady growth supported by continuous product innovation and expanding clinical applications across global healthcare networks.
Market Overview
The Biopsy Devices Market is witnessing strong global adoption as healthcare providers increasingly rely on tissue sampling tools for accurate disease diagnosis. Moreover, Expert Market Research notes that biopsy instruments are essential in identifying cancer, infections, and inflammatory disorders across multiple organ systems. Additionally, advancements in medical imaging and minimally invasive techniques are reshaping procedural efficiency. Consequently, demand is rising across hospitals, diagnostic centers, and specialized cancer institutions worldwide.
Market Size & Forecast: Expert Market Research Projections
The Biopsy Devices Market was valued at USD 7.82 Billion in 2025 and is expected to expand at a CAGR of 7.6% during 2026–2035, reaching USD 16.27 Billion by 2035, as per Expert Market Research analysis. Furthermore, this growth reflects increasing diagnostic demand and continuous technological advancements. Additionally, expanding healthcare investments and rising cancer screening programs are contributing to sustained market expansion globally over the forecast period.
Macroeconomic & Industry Linkage Analysis
Moreover, macroeconomic conditions such as rising healthcare expenditure and improved insurance coverage are positively influencing market adoption. Consequently, governments across developing economies are investing in diagnostic infrastructure. Additionally, Expert Market Research highlights that economic development directly correlates with improved access to advanced medical technologies, including biopsy systems used in oncology and pathology.
Furthermore, global healthcare digitization and hospital modernization programs are accelerating adoption of advanced biopsy tools. Meanwhile, increasing collaboration between medical device companies and healthcare institutions is supporting innovation. Therefore, macroeconomic stability and healthcare reforms are jointly strengthening market growth prospects worldwide.
Key Growth Drivers
- Rising cancer prevalence: Increasing incidence of cancer is driving demand for accurate diagnostic biopsy tools globally.
- Technological advancements: Innovation in image-guided and liquid biopsy systems is improving diagnostic precision.
- Growing healthcare infrastructure: Expansion of hospitals and diagnostic centers is supporting device adoption.
- Increasing screening programs: Government initiatives are promoting early detection and preventive diagnostics.
- Rising demand for minimally invasive procedures: Patients and physicians prefer safer and faster diagnostic techniques.
Market Trends
Moreover, a key trend identified by Expert Market Research is the shift toward minimally invasive biopsy procedures. Additionally, liquid biopsy technologies are gaining traction due to their ability to detect diseases through blood samples. Consequently, healthcare providers are increasingly integrating advanced imaging guidance systems to enhance procedural accuracy and reduce patient discomfort.
Furthermore, digital pathology integration is emerging as a strong trend across diagnostic laboratories. Meanwhile, manufacturers are focusing on developing portable and user-friendly biopsy devices. Therefore, innovation and digital transformation are shaping the future landscape of the global biopsy devices industry.
Market Challenges & Risk Factors
However, high equipment costs remain a significant barrier to adoption in emerging regions. Additionally, limited access to advanced healthcare infrastructure can restrict market penetration. Furthermore, Expert Market Research notes that regulatory complexities may delay product approvals in certain markets, impacting overall commercialization timelines.
Moreover, skilled professional shortages in pathology and radiology can hinder optimal device utilization. Consequently, training and education gaps may slow adoption rates. Therefore, addressing affordability and accessibility challenges remains critical for sustained industry expansion.
Market Opportunities & White Space Areas
Moreover, emerging economies present strong growth opportunities due to expanding healthcare investments. Additionally, the increasing adoption of point-of-care diagnostics is opening new application areas. Furthermore, Expert Market Research emphasizes that AI-driven biopsy interpretation tools represent a significant white space opportunity in the coming years.
Consequently, manufacturers focusing on portable, cost-effective solutions can capture untapped demand. Meanwhile, partnerships with healthcare providers are expected to enhance market penetration. Therefore, innovation-driven expansion strategies will define future competitive advantage.
Value Chain & Supply Chain Analysis
The biopsy devices value chain includes raw material suppliers, component manufacturers, device assemblers, distributors, and end users such as hospitals and diagnostic centers. Moreover, Expert Market Research highlights that efficient supply chain integration ensures timely delivery and cost optimization. Additionally, regulatory compliance and quality assurance play a crucial role in maintaining product reliability and clinical safety standards across global markets.
Market Segmentation Analysis
Breakup by Product
- Needle Based Biopsy Instruments
- Liquid Biopsy Instruments
- Biopsy table
- Localization Wire
- Procedure Tray
- Others
Breakup by Guidance Technique
- Image Guided Biopsy
- Non-Image Guided Biopsy
Breakup by Application
- Lung Cancer
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Bone Marrow Biopsy
- Others
Breakup by End User
- Hospitals and Clinics
- Diagnostic Centers
- Cancer Centers
- Academic and Research Institutes
- Others
Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Competitive Landscape
| Company | Headquarters | Key Focus Area |
|---|---|---|
| Becton, Dickinson and Company | United States | Biopsy instruments and diagnostic systems |
| Cook Group Incorporated | United States | Minimally invasive medical devices |
| Devicor Medical Products, Inc. | United States | Breast biopsy systems |
| Hologic Inc. | United States | Women’s health diagnostics |
| Argon Medical Devices, Inc. | United States | Interventional biopsy devices |
| B. Braun Medical Inc. | Germany | Surgical and diagnostic instruments |
| Cardinal Health, Inc. | United States | Medical distribution and devices |
| Olympus Corporation. | Japan | Endoscopy and imaging systems |
| Boston Scientific Corporation | United States | Interventional medical solutions |
| Medtronic plc | Ireland | Advanced medical technologies |
| FUJIFILM Holdings Corporation. | Japan | Imaging and diagnostic solutions |
Frequently Asked Questions (FAQs)
1. What is the current size of the Biopsy Devices Market?
USD 7.82 Billion in 2025.
2. What is the projected CAGR of the Biopsy Devices Market?
The market is expected to grow at a CAGR of 7.6% during 2026–2035.
3. Which region dominates the Biopsy Devices Market?
North America dominates the market due to advanced healthcare infrastructure and high adoption rates.
4. Who are the key players in the Biopsy Devices Market?
Becton, Dickinson and Company, Cook Group Incorporated, Devicor Medical Products, Inc., Hologic Inc., Argon Medical Devices, Inc., B. Braun Medical Inc., Cardinal Health, Inc., Olympus Corporation., Boston Scientific Corporation, Medtronic plc, FUJIFILM Holdings Corporation.
5. What are the major growth drivers of the Biopsy Devices Market?
Rising cancer prevalence, technological advancements, and expanding healthcare infrastructure are key drivers as per Expert Market Research.
6. What are the key segments of the Biopsy Devices Market?
Product, guidance technique, application, end user, and region segments define the market structure.
7. What challenges does the Biopsy Devices Market face?
High costs, regulatory delays, and limited skilled workforce remain key challenges according to Expert Market Research.
8. What is the forecast value of the Biopsy Devices Market by 2035?
USD 16.27 Billion by 2035.
About Us:
Expert Market Research is a leading market intelligence and consulting platform delivering data-driven insights across commodities, chemicals, energy, and industrial markets. Our research helps businesses, analysts, investors, and procurement teams understand price trends, supply-demand dynamics, competitive landscapes, benchmark best practices, and develop long-term market strategies.
Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy,
consistency, and relevance. Our analysis is widely used not only for strategic planning,
market-entry assessments, and sourcing decisions, but also for investment evaluation across
international markets. Our strong emphasis on transparency, factual reporting, and regular
data updates to reflect real-time market conditions always keeps you ahead of the curve.
Media Contact:
Company Name: Expert Market Research
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com